Description, comparison with clinical data and clinical exploitation of a non-invasive and relatively inexpensive method for screening cardiovascular systems based on multi-parameter analysis of heart haemodynamics and vascular perfusion in selected areas of the body.
Development of a new, innovative medical apparatus for the artificial ventilation of lungs of intensive care patients and as extra support during emergencies (e.G. Terrorist attack or natural disaster).
The project includes developing the equipment to verify a new diagnostic method based on non-invasive cardio-stimulation. This will enable risk assessment of coronary diseases during screening tests of populations at risk.
Experimental production of prototype radioimmunology reagents based on engineered antibodies harbouring all desired properties (e.G. Affinity, stability, non-immunogenicity and high levels of labelling) in combination.
New methods and techniques for modifying polymer foils to improve their bio-functions using extreme ultraviolet (euv) radiation from laser plasma light sources which will be developed during the project for biomedical technology.
The project will develop a new technology platform integrating photonic crystals with new laser technology using gan. To illustrate the power of the technology, we will develop a prototype of a new medical device for early detection of cancer.
To develop and produce an efficient nasal spray protecting the nasal mucosa from infections and preventing disease.
To develop a new medical tampon for gynaecological use based on incorporation of chitosan nanoparticle onto cellulose tampon which will provide an optimal and controlled diffusion of antimicrobial substance into the vaginal and cervical mucosa membrane.
The aim is research end development of natural antimicrobial medicaments of non-antibiotic character determined for therapy for animals. These medicaments have purpose to reduce or in some cases replace antibiotics, which are currently for animals used to excess.
Multi-platform Colorectal Cancer Genetic Testing Portfolio